rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

John Patience

Director and Other role

Company insider

Files Form 4 as: Director and 10% owner and Other, Biodesix; Director and 10% owner, Accelerate Diagnostics; Director, Stericycle; Director, Ventana Medical Systems.

Every Form 4 they filed

In numbers

Trades disclosed
254
Buys
26
Sells
10
Bought
$30.8M
Sold
$20.7M
Companies
4
Companies where not an officer
4
First trade
15 Dec 2005
Last trade
30 Sep 2026
Last filed
2 Oct 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
BDSX BiodesixDirector, 10% owner, Other · Diagnostics & Labs · last 30 Sep 20269 buys · 0 sells
Accelerate DiagnosticsDirector, 10% owner · last 3 Dec 202413 buys · 0 sells
StericycleDirector · last 23 May 20184 buys · 10 sells
Ventana Medical SystemsDirector · last 19 Feb 20080 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
30 Sep 2026filed 2 Oct 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Code M—1,360filing
30 Sep 2026filed 2 Oct 2026BDSX Biodesixoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—1,360 at $0.00filing
30 Jun 2026filed 2 Jul 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Code M—1,361filing
30 Jun 2026filed 2 Jul 2026BDSX Biodesixoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—1,361 at $0.00filing
30 Jun 2026filed 2 Jul 2026BDSX Biodesixoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—1,361 at $0.00filing
30 Jun 2026filed 2 Jul 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Code M—1,361filing
31 Mar 2026filed 2 Apr 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Code M—1,361filing
31 Mar 2026filed 2 Apr 2026BDSX Biodesixoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—1,361 at $0.00filing
31 Mar 2026filed 2 Apr 2026BDSX Biodesixoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—1,361 at $0.00filing
31 Mar 2026filed 2 Apr 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Code M—1,361filing
5 Jan 2026filed 6 Jan 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Code M—1,143filing
5 Jan 2026filed 6 Jan 2026BDSX Biodesixoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—1,143 at $0.00filing
5 Jan 2026filed 6 Jan 2026BDSX Biodesixoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—1,143 at $0.00filing
5 Jan 2026filed 6 Jan 2026BDSX BiodesixDiagnostics & LabsSEC FORM 4 Code M—1,143filing
2 Jan 2026filed 6 Jan 2026BDSX Biodesixoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—5,443 at $0.00filing
2 Jan 2026filed 6 Jan 2026BDSX Biodesixoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—6,354 at $0.00filing
2 Jan 2026filed 6 Jan 2026BDSX Biodesixoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—5,443 at $0.00filing
2 Jan 2026filed 6 Jan 2026BDSX Biodesixoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—6,354 at $0.00filing
30 Sep 2025filed 2 Oct 2025BDSX Biodesixoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—1,144 at $0.00filing
30 Sep 2025filed 2 Oct 2025BDSX BiodesixDiagnostics & LabsSEC FORM 4 Code M—1,144filing

Sectors

Health Care9
Not placed27

Buys in green, sells in red, by the company’s sector.

Related people

Jack W. Schuler10% owner and Other role · 10% owner and Other at Biodesix, filing Form 4 there in the last year
Chris VazquezChief Accounting Officer · Chief Accounting Officer at Biodesix, filing Form 4 there in the last year
Scott HuttonPresident & CEO · President & CEO at Biodesix, filing Form 4 there in the last year
Robin Harper CowieCFO, Sec'y & Treasurer · CFO, Sec'y & Treasurer at Biodesix, filing Form 4 there in the last year
Gary Anthony PestanoChief Development Officer · Chief Development Officer at Biodesix, filing Form 4 there in the last year